• SLDB is trading at $10.50, down 5.8% in pre-market action, easing back after a strong multi-day rally.
  • The rally, which saw the stock rise roughly 20% over the past two weeks, was notably driven by Solid Biosciences' inclusion in the Russell 2000 Growth and Russell 3000 Growth indices in late June.
  • Today's move appears to be a result of profit-taking following this significant index-driven surge, amidst a broader risk-off sentiment in equity futures this morning.